3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
5
Neoplasms
3
Leukemia, Myeloid, Acute
3
Ovarian Neoplasms
2
Wilms Tumor
1
Triple Negative Breast Neoplasms
1
Small Cell Lung Carcinoma
1
Skin Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pathologic Complete Response
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Mesothelioma, Malignant
1
Leukemia
1
Fallopian Tube Neoplasms
1
Colorectal Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Carcinogenesis
1
Interventions
Temozolomide
53
Bevacizumab
45
Radiotherapy
28
Radiosurgery
21
Carboplatin
14
Erlotinib Hydrochloride
11
Radiation
10
pembrolizumab
9
Magnetic Resonance Spectroscopy
9
Etoposide
9
Vorinostat
8
Trastuzumab
8
Irinotecan
8
Sunitinib
7
Sorafenib
7
Radiotherapy, Intensity-Modulated
7
Lomustine
7
Lapatinib
7
Capecitabine
7
dabrafenib
6
Ipilimumab
6
Imatinib Mesylate
6
Cyclophosphamide
6
Sirolimus
5
Hydroxyurea
5
Everolimus
5
Bortezomib
5
temsirolimus
4
cabozantinib
4
binimetinib
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Brain Neoplasms
×
Monatide (IMS 3015)
×
Clear all
No trials found.